Clobazam Dosage and Usage for Anxiety Disorders and Epilepsy Management
For epilepsy management, clobazam is dosed according to body weight: patients ≤30 kg should start at 5 mg daily and titrate up to 20 mg daily, while patients >30 kg should start at 10 mg daily and titrate up to 40 mg daily, with dose escalation occurring no more rapidly than weekly. 1
Dosing for Epilepsy (Lennox-Gastaut Syndrome)
Weight-Based Dosing
For patients ≤30 kg:
For patients >30 kg:
Administration Guidelines
- Daily doses >5 mg should be administered in divided doses twice daily 1
- A 5 mg daily dose can be administered as a single dose 1
- Clobazam can be taken with or without food 1
- Do not escalate doses more rapidly than weekly, as clobazam and its active metabolite require 5 and 9 days, respectively, to reach steady-state 1
Special Populations
Elderly Patients
- Starting dose: 5 mg/day for all elderly patients 1
- Titrate according to weight, but to half the standard dose as tolerated 1
- If necessary, an additional titration to the maximum dose (20 mg/day or 40 mg/day, depending on weight) may be started on day 21 1
CYP2C19 Poor Metabolizers
- Starting dose: 5 mg/day 1
- Titrate slowly according to weight, but to half the standard dose as tolerated 1
- If necessary, an additional titration to the maximum dose (20 mg/day or 40 mg/day, depending on weight) may be started on day 21 1
Renal Impairment
- No dose adjustment required for mild to moderate renal impairment 1
- Limited data available for severe renal impairment or end-stage renal disease 1
Hepatic Impairment
- Proceed slowly with dose escalation in patients with hepatic impairment 1
Use in Anxiety Disorders
While clobazam is primarily indicated for epilepsy in the US (specifically Lennox-Gastaut syndrome), it has been used internationally for anxiety disorders:
- Typical dosage for anxiety: 20-30 mg/day 2
- Can be administered as either a single daily dose or divided doses 3, 4
- Studies have shown that single daily dosing (20 mg at night) is as effective as divided dosing (10 mg twice daily) for anxiety 3, 4
Important Safety Considerations
Risks and Warnings
- Concomitant use with opioids may result in profound sedation, respiratory depression, coma, and death 1
- Risk of abuse, misuse, and addiction 1
- Abrupt discontinuation may precipitate withdrawal reactions 1
Discontinuation Protocol
- Use a gradual taper to discontinue clobazam or reduce the dosage 1
- Taper by decreasing the total daily dose by 5-10 mg/day on a weekly basis until discontinued 1
- If withdrawal reactions occur, consider pausing the taper or increasing to the previous dosage level, then decrease more slowly 1
Common Side Effects
Clinical Efficacy
- In refractory epilepsy, clobazam has shown >50% reduction in seizure frequency in 40-50% of patients 5
- Complete seizure freedom (100% reduction) has been reported in 10-30% of patients 5
- Tolerance leading to discontinuation occurs in approximately 9% of patients 5
- Clobazam has demonstrated efficacy as both adjunctive therapy and in limited monotherapy trials 6
Clobazam's unique 1,5-benzodiazepine structure results in less sedation compared to other benzodiazepines, making it valuable for both epilepsy management and anxiety treatment when appropriate 6.